Pregnolia developed an innovative system to accurately assess the stiffness of the cervical tissue of pregnant and non-pregnant women.
Pregnolia ensures that every woman can have a happy, healthy and informed pregnancy until term. Their team knows that the existing research about preterm birth assessment is very promising, but this alone does not guarantee success. Sabrina, Francisco and Annette are highly committed to develop the commercial version of the device, complete the clinical trial, follow the regulatory roadmap and execute on their business vision to successfully support gynaecologists in improving the preterm birth risk assessment and birth management.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jun 25, 2020 | Series A | Fr4.20M | 1 | — | — | Detail |
Apr 24, 2020 | Series A | Fr5M | 1 | — | — | Detail |
Feb 14, 2018 | Seed | Fr3.25M | 1 | Verve Ventures | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Verve Ventures | — | Series A |
SwissHealth Ventures | — | Series A |